Market report
Dermatological drug tenders in Czechia — market report, April 2026
Dermatological drug tenders in Czechia in April 2026: 7,143 tenders published (-6% month on month, -11% year on year), and 7,177 contracts awarded (-5% month on month, -11% year on year), worth €75,059,756 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (1,939), Krajská zdravotní, a.s. (862) and Fakultní nemocnice Bulovka (562); most contracts won: Takeda Pharmaceuticals Czech Republic s.r.o. (174), ViaPharma s.r.o. (167) and ROCHE s.r.o. (166). On average 1.7 bids per contract; 74% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 7,143
- Contracts awarded
- 7,177
- Contract value awarded
- €75,059,756
- Bids per contract
- 1.7
The highlighted bar is April 2026. Hover a bar for its figure; the table below has every value.
| Figure | April 2026 | March 2026 | Change | April 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 7,143 | 7,582 | -6% | 8,045 | -11% |
| Estimated value | — | €1,828,501 | — | €6,934,584 | — |
| Buyers | 30 | 34 | -12% | 31 | -3% |
| Contracts awarded | 7,177 | 7,586 | -5% | 8,051 | -11% |
| Contract value (awarded) | €75,059,756 | €32,119,827 | +134% | €5,714,987 | +1,213% |
| Winners | 307 | 310 | -1% | 264 | +16% |
| Bids per contract | 1.7 | 1.4 | — | 1.1 | — |
| Single-bid contracts | 74% | 73% | — | 90% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | Takeda Pharmaceuticals Czech Republic s.r.o. | 174 |
| 2 | ViaPharma s.r.o. | 167 |
| 3 | ROCHE s.r.o. | 166 |
| 4 | AbbVie s.r.o. | 122 |
| 5 | Janssen-Cilag s.r.o. | 116 |
| 6 | Amgen s.r.o. | 100 |
| 7 | Gilead Sciences s.r.o. | 91 |
| 8 | BAYER s.r.o. | 87 |
| 9 | Avenier a.s. | 81 |
| 10 | FAGRON a.s. | 71 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in April 2026?
- 7,143 (by 30 buyers); for comparison, March 2026: 7,582, April 2025: 8,045.
- Who won the most dermatological drug tenders in Czechia in April 2026?
- By number of contracts: Takeda Pharmaceuticals Czech Republic s.r.o. (174), ViaPharma s.r.o. (167), ROCHE s.r.o. (166), AbbVie s.r.o. (122) and Janssen-Cilag s.r.o. (116); 307 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in April 2026?
- Krajská nemocnice T. Bati, a. s. (1,939), Krajská zdravotní, a.s. (862), Fakultní nemocnice Bulovka (562), Fakultní nemocnice Brno (470) and Nemocnice České Budějovice, a.s. (367).
- How competitive were dermatological drug tenders in Czechia in April 2026?
- On average 1.7 bids per contract (35 contracts with a known number of bids); 74% of contracts had a single bid.
- What were the contracts worth in April 2026?
- €75,059,756 (awarded value, 7,177 contracts); median about €1,400,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.